These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs? Church MK Agents Actions; 1986 Jun; 18(3-4):288-93. PubMed ID: 2428217 [No Abstract] [Full Text] [Related]
24. Pharmacology of the late response to allergen and its relevance to asthma prophylaxis. Morley J; Page CP; Sanjar S Int Arch Allergy Appl Immunol; 1985; 77(1-2):73-8. PubMed ID: 3924841 [TBL] [Abstract][Full Text] [Related]
25. Current status of PAF antagonists. Heuer HO Clin Exp Allergy; 1992 Nov; 22(11):980-3. PubMed ID: 1468031 [No Abstract] [Full Text] [Related]
27. New concepts in the pathogenesis of bronchial hyperresponsiveness. Barnes PJ Agents Actions Suppl; 1987; 21():225-37. PubMed ID: 3314413 [No Abstract] [Full Text] [Related]
28. Current concepts in asthma. Mathur RS; Chitnis AS; Shah JR J Assoc Physicians India; 1987 Feb; 35(2):141-6. PubMed ID: 3320019 [No Abstract] [Full Text] [Related]
29. Cromolyn sodium in the treatment of asthma: coming of age in the United States. Bernstein IL J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):381-8. PubMed ID: 3926853 [TBL] [Abstract][Full Text] [Related]
30. [Drug therapy of asthma by antiallergic agents]. Yano S Nihon Naika Gakkai Zasshi; 1992 Jun; 81(6):830-4. PubMed ID: 1383362 [No Abstract] [Full Text] [Related]
32. Cromolyn sodium: a new approach to treatment of asthma. Ward J Heart Lung; 1975; 4(3):415-9. PubMed ID: 805781 [No Abstract] [Full Text] [Related]
33. [The significance of platelet activating factor and its antagonists in bronchial asthma]. Beume R; Kilian U Med Klin (Munich); 1989 Jun; 84(6):286-93. PubMed ID: 2547143 [No Abstract] [Full Text] [Related]
34. [Function of platelet activating factor in asthma]. Ukena D; Sybrecht GW Dtsch Med Wochenschr; 1988 Oct; 113(42):1651-6. PubMed ID: 2846251 [No Abstract] [Full Text] [Related]
35. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Brogden RN; Speight TM; Avery GS Drugs; 1974; 7(3):164-282. PubMed ID: 4212341 [No Abstract] [Full Text] [Related]
36. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Kay AB Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559 [TBL] [Abstract][Full Text] [Related]